KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Short-Term Debt issuances (2017 - 2025)

Boston Scientific's Short-Term Debt issuances history spans 8 years, with the latest figure at -$192.0 million for Q1 2025.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$192.0 million in Q1 2025 year-over-year; TTM through Mar 2026 was -$5.0 million, a 0.0% change, with the full-year FY2025 number at -$196.0 million, down 204.81% from a year prior.
  • Short-Term Debt issuances hit -$192.0 million in Q1 2025 for Boston Scientific, down from $187.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for BSX hit a ceiling of $223.0 million in Q1 2022 and a floor of -$192.0 million in Q1 2025.
  • Historically, Short-Term Debt issuances has averaged -$1.0 million across 4 years, with a median of -$4.0 million in 2023.
  • Biggest five-year swings in Short-Term Debt issuances: crashed 500.0% in 2023 and later soared 4775.0% in 2024.
  • Tracing BSX's Short-Term Debt issuances over 4 years: stood at $1.0 million in 2022, then crashed by 500.0% to -$4.0 million in 2023, then soared by 4775.0% to $187.0 million in 2024, then plummeted by 202.67% to -$192.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for BSX at -$192.0 million in Q1 2025, $187.0 million in Q4 2024, and -$4.0 million in Q4 2023.